CG&D
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pellegrini, R.
Right arrow Articles by Radice, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pellegrini, R.
Right arrow Articles by Radice, P.

Cell Growth & Differentiation, Vol 6, Issue 7 863-869, Copyright © 1995 by American Association of Cancer Research


ARTICLES

Modulation of markers associated with tumor aggressiveness in human breast cancer cell lines by N-(4-hydroxyphenyl) retinamide

R Pellegrini, A Mariotti, E Tagliabue, R Bressan, G Bunone, D Coradini, G Della Valle, F Formelli, L Cleris and P Radice
Dipartimento di Oncologia Sperimentale, Istituto Nazionale Tumori, Milano, Italy.

The retinoid N-(hydroxyphenyl) retinamide (4-HPR) appears to be a promising tool for chemoprevention of breast carcinoma, and clinical trials to evaluate its effect are in progress. However, its action on tumor cells has remained largely undefined. We report here that 4-HPR induced apoptosis and/or differentiation in breast cancer cell lines, independent of hormone receptor status and retinoic acid receptor expression, although it was slightly more efficient in inhibiting proliferation of estrogen receptor-positive cells. 4-HPR up-modulated expression of several differentiation markers (class 1 HLA, laminin, and beta 1 integrin chain) and down-regulated expression of molecules associated with tumor progression, including the p185/HER2 oncoprotein, the epidermal growth factor receptor, and the M(r) 67,000 laminin receptor. These data suggest that 4-HPR could exert a beneficial effect by inhibiting cell proliferation and modulating breast tumor aggressiveness.


This article has been cited by other articles:


Home page
JCOHome page
A. Decensi, C. Robertson, A. Guerrieri-Gonzaga, D. Serrano, M. Cazzaniga, S. Mora, M. Gulisano, H. Johansson, V. Galimberti, E. Cassano, et al.
Randomized Double-Blind 2 x 2 Trial of Low-Dose Tamoxifen and Fenretinide for Breast Cancer Prevention in High-Risk Premenopausal Women
J. Clin. Oncol., August 10, 2009; 27(23): 3749 - 3756.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. L. Anding, J. S. Chapman, D. W. Barnett, R. W. Curley Jr., and M. Clagett-Dame
The Unhydrolyzable Fenretinide Analogue 4-Hydroxybenzylretinone Induces the Proapoptotic Genes GADD153 (CHOP) and Bcl-2-Binding Component 3 (PUMA) and Apoptosis that Is Caspase- Dependent and Independent of the Retinoic Acid Receptor
Cancer Res., July 1, 2007; 67(13): 6270 - 6277.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
J. G. Villablanca, M. D. Krailo, M. M. Ames, J. M. Reid, G. H. Reaman, and C. P. Reynolds
Phase I Trial of Oral Fenretinide in Children With High-Risk Solid Tumors: A Report From the Children's Oncology Group (CCG 09709)
J. Clin. Oncol., July 20, 2006; 24(21): 3423 - 3430.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
K. J. Soprano and D. R. Soprano
Retinoic Acid Receptors and Cancer
J. Nutr., December 1, 2002; 132(12): 3809S - 3813.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. M. Schneider, M. Offterdinger, H. Huber, and T. W. Grunt
Activation of Retinoic Acid Receptor {{alpha}} Is Sufficient for Full Induction of Retinoid Responses in SK-BR-3 and T47D Human Breast Cancer Cells
Cancer Res., October 1, 2000; 60(19): 5479 - 5487.
[Abstract] [Full Text]


Home page
Cancer Res.Home page
M. Campiglio, Y. Pekarsky, S. Menard, E. Tagliabue, S. Pilotti, and C. M. Croce
FHIT Loss of Function in Human Primary Breast Cancer Correlates with Advanced Stage of the Disease
Cancer Res., August 1, 1999; 59(16): 3866 - 3869.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
R. K. Srivastava, A. R. Srivastava, Y. S. Cho-Chung, and D. L. Longo
Synergistic Effects of Retinoic Acid and 8-Chloro-Adenosine 3',5'-Cyclic Monophosphate on the Regulation of Retinoic Acid Receptor {beta} and Apoptosis: Involvement of Mitochondria
Clin. Cancer Res., July 1, 1999; 5(7): 1892 - 1904.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
A. N. Fanjul, D. Delia, M. A. Pierotti, D. Rideout, J. Qiu, and M. Pfahl
4-Hydroxyphenyl Retinamide Is a Highly Selective Activator of Retinoid Receptors
J. Biol. Chem., September 13, 1996; 271(37): 22441 - 22446.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation
Copyright © 1995 by the American Association of Cancer Research.